Dexlansoprazole Capsule, Delayed Release
Product Images NDC 70518-4791

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 70518-4791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

Chemical structure of dexlansoprazole, the active ingredient in Dexlansoprazole delayed release 60 mg capsules, as shown in the molecular diagram. This structure highlights the arrangement of atoms for the active drug compound.*

FDA Label Image

Figure 1 (Dexlansoprazole 02)

A line chart displaying plasma concentration (ng/mL) versus time (hours) for dexlansoprazole delayed release at 30 mg and 60 mg doses. The graph shows time points up to 24 hours and indicates higher plasma concentrations with the 60 mg dose across the measured time period.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Dexlansoprazole 60 mg delayed-release capsules, quantity of 30 capsules per package. The label includes the NDC number 70518-4791-00 and indicates repackaging by RemedyRepack Inc. Storage instructions specify 20-25°C with permitted excursions to 15-30°C. Manufacturer is Upsher-Smith Labs, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.